Skip to Content

Xcelerate Inc - Stock Quote XCRT

Rating as of

Morningstar's Xcelerate Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - XCRT

Xcelerate Inc's Company Profile

Business Description

Xcelerate Inc has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. It intends to acquire innovation at the engineering/patent level, marry it with appropriate early-stage operational med-tech companies and apply it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella.

110 Renaissance Circle
Mauldin, SC, 29662
T +1 854 900-2020
Industry Medical Care Facilities
Most Recent Earnings Sep 30, 2008
Fiscal Year End Dec 31, 2022
Stock Type Speculative Growth
Employees 23